C-reactive protein and vascular risk: from March to Jupiter.
Di Angelantonio
Emanuele
E
Cohen
Ariel
A
D002097:C-Reactive Protein / Q000502:physiology*; D002318:Cardiovascular Diseases / Q000097:blood / Q000453:epidemiology* / Q000503:physiopathology; D015984:Causality; D003324:Coronary Artery Disease / Q000097:blood / Q000517:prevention & control; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000097:blood / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002097:C-Reactive Protein